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Introduction {#sec005}
============

Rhinovirus (HRV) is not only a pathogen for the common cold, but is also the major cause of acute asthma and chronic obstructive pulmonary disease (COPD) exacerbations \[[@pone.0118286.ref001],[@pone.0118286.ref002],[@pone.0118286.ref003]\]. Virus-induced asthma exacerbations are not sufficiently controlled by currently available standard-of-care drugs \[[@pone.0118286.ref001]\]. An increased understanding of mechanisms linking HRV infections to asthma induction and exacerbations will provide insights for development of novel therapies for improved asthma management.

Human airway epithelial cells (HAECs) are the principal sites of HRV infection in both upper and lower airways \[[@pone.0118286.ref004]\]. HAECs act not only as the first line of defense against HRV, but also induce release of a wide range of mediators that drive subsequent immune and physiological responses specific to HRV \[[@pone.0118286.ref005]\]. Much of our current knowledge of HAEC responses to HRV infection is derived from *in vitro* HAEC culture studies. Two major approaches used to study *in vitro* responses to HRV infection include use of undifferentiated HAEC monolayers in submerged (Sub) cultures, and well-differentiated HAEC cultured in air-liquid interface (ALI) systems \[[@pone.0118286.ref006],[@pone.0118286.ref007]\]. Sub cultures have been useful models for the study of HRV infection due to their ready availability, ease of culture, and facile infectability \[[@pone.0118286.ref008]\]. However, Sub cultures do not reproduce the structural and functional phenotype of differentiated *in vivo* airway epithelium \[[@pone.0118286.ref009]\], and differentiated ALI cells are considered to provide a better representation of *in vivo* airway epithelial transcription than Sub cultures (29). Differentiation of HAECs has been reported to induce resistance to HRV infection \[[@pone.0118286.ref010]\]. However, it is unclear whether the reported difficulty of infecting differentiated ALI cultures was due to physical reasons, such as development of physical/biochemical barriers \[[@pone.0118286.ref011]\], or technical reasons, such as the HRV application protocol or the relatively short time period of exposure utilized in the experiments \[[@pone.0118286.ref010]\].

The ability of asthmatic-derived HAEC to reproduce the asthmatic phenotype when cultured *in vitro* has been the subject of considerable recent interest. Several previously published studies indicate that asthmatic HAECs will maintain certain asthmatic features in response to HRV infection, RSV infection, air pollution, cigarette smoke or physical damage *in vitro* \[[@pone.0118286.ref012],[@pone.0118286.ref013],[@pone.0118286.ref014],[@pone.0118286.ref015]\]. However, additional confirmation of disease phenotype maintenance is needed, particularly for passaged cells and differentiated culture models \[[@pone.0118286.ref016],[@pone.0118286.ref017]\].

To gain an increased understanding of mechanisms linking HRV infection of HAECs to asthma induction and exacerbations, the goals of the current study were to evaluate ALI HAEC culture models for HRV infection, and to further identify unique gene expression patterns associated with asthmatic epithelium and HRV infection. We demonstrated efficient HRV infectability of HAEC ALI cultures, and many aspects of gene expression responses to infection that are consistent with *in vivo* human clinical findings. Previously known genes, as well as novel genes that are associated with asthma specific viral responses were identified. We conclude that ALI cultures of HAECs are useful translational models for studies of rhinovirus induced epithelial effects related to asthma exacerbation *in vitro*. Furthermore, our data suggest that abnormal airway epithelial structure and inflammatory signaling may be important contributors to viral induced asthma exacerbation.

Materials and Methods {#sec006}
=====================

HAEC culture, infection and sample preparation {#sec007}
----------------------------------------------

Non-transplantable lungs (6 non-asthmatic and 6 asthmatic individuals) donated for medical research were obtained through the International Institute for the Advancement of Medicine (IIAM, Edison, NJ; <http://www.iiam.org/>) ([Table 1](#pone.0118286.t001){ref-type="table"}). Signed consent to procure the tissues was obtained by IIAM. All donor identification information was removed from the sample labels by IIAM before receipt to protect the donor's confidentiality. Donor deaths were primarily attributable to head trauma in non-asthmatic patients, whereas patients with asthma died subsequent to asthma exacerbations. Donor medical history was provided by IIAM based on physicians' report/diagnosis and interview of family members by trained clinicians following death. Epithelial cells were isolated and cultured at passage 2 as previously described \[[@pone.0118286.ref015]\]. ALI cultures (0.6 cm^2^ insert devices from Millipore) were maintained in 6-well dishes containing 1 mL/well of hydrocortisone-free media for 24 hours (37°C, 5% CO~2~). The apical surface of ALI cultures was gently washed twice with 300 μL PBS to remove accumulated mucus, prior to an apical application of 50 μL vehicle (complete EMEM medium), or RV-A16 (ATCC, Manassas, VA) (5x10^5^ plaque-forming units \[pfu\] in 50 μL complete EMEM medium) based on an estimated *in vivo* infection dose from Chen et al.\[[@pone.0118286.ref018]\]. Viral titer was determined by diluting viral samples in half log units, and testing their cytopathic effects on confluent H1Hela cells (ATCC) in 24 well plates following the standard protocol \[[@pone.0118286.ref019]\] to obtain TCID50/mL in 5 days. The titer in pfu was calculated as 0.69xTCID50/mL, which was consistent with the titer obtained using a standard plaque assay provided by ATCC. Treated cultures were shifted to a 34°C incubator (5% CO~2~) with gentle shaking on a Bellco orbital shaker until harvested at 1.5, 8, 24 or 48 hours. Subsequent to incubation, media were harvested for secreted chemokine/cytokine assessment and immediately placed on ice, and then analyzed using a 42-plex Luminex kit (Millipore, Billerica, MA). For RNA preparation, cells were washed three times with PBS, followed by adding 175 μL RLT buffer (Qiagen) to each ALI insert. ALI cell lysates were transferred to tubes on ice, and ALI inserts were further rinsed and samples were pooled with an additional 175 μL aliquot of RLT (350 μL total/sample).

10.1371/journal.pone.0118286.t001

###### Donor information.

![](pone.0118286.t001){#pone.0118286.t001g}

  Donor \#   Asthma   Gender   Age   Race   Smoking      Height (inches)   Weight (Pounds)   Other Disease     Medications
  ---------- -------- -------- ----- ------ ------------ ----------------- ----------------- ----------------- ------------------------------------------
  11         No       F        38    C      Yes. 16 PY   65                106                                 
  12         Yes      F        59    H      No           60                194               COPD, D, HTN      Advair
  14         Yes      F        46    C      Yes. 30 PY   69                305               D                 
  15         Yes      F        45    C      Yes. 30 PY   62                165               COPD, D, HTN, G   Albuterol, Advair
  18         Yes      F        64    C      No           65                189               COPD, D, HTN      Advair, Albuterol
  20         No       M        13    C      No           73                220                                 
  21         No       F        62    B      No           66                207                                 
  22         No       M        35    C      No           68                205               HTN               Copazine, benadryl, lisinopril, darvocet
  23         No       M        52    C      Yes. 20PY    69                167                                 
  26         Yes      F        9     B      No           52                88                                  Albuterol, Advair
  28         Yes      F        55    C      Yes. Light   65                258               D, HTN            Prednisone, Albuterol inhaler, others
  30         No       M        50    H      No           72                216                                  

Abbreviations: F, Female; M, Male; C, Caucasian; H, Hispanic; B, Black; PY, Pack-Year, D; Diabetes, HTN; Hypertension, G; Glaucoma

Immunohistochemistry {#sec008}
--------------------

ALI cultured cells were fixed in 10% buffered formalin overnight, then paraffin embedded and sectioned. After antigen retrieval, slides were stained and imaged using an Olympus FluoView FV1000 confocal microscope, and analyzed using the Nikon NIS Elements software. Primary antibodies mouse anti-Muc5AC (Millipore, MAB2011), mabj2 \[[@pone.0118286.ref020]\], or isotype matched immunoglobins were followed by Alexa Fluor conjugated goat anti-mouse and DAPI (Life Technologies).

RNA isolation and analysis {#sec009}
--------------------------

Total RNA was isolated from RLT cell lysates using the QIAGEN RNeasy mini kit, and quantified via Nanodrop (Thermo Scientific, Wilmington, DE), and subjected to qRT-PCR analysis. qRT-PCR primers for human genes were obtained from ABI (<http://www.lifetechnologies.com>). RV-A16 genome was measured by qPCR using the PrimerDesign Quantification kit for human rhinovirus 16 (genesig). To determine the copies of viral RNA in cell lysates for samples from both control and RV-A16 treatments, qPCR values were compared with the standard curve generated by using the RV-A16 positive control RNA template provided with the kit.

Data analysis for secreted protein results {#sec010}
------------------------------------------

A linear mixed model was fit to data for each analyte using the MIXED procedure in SAS (SAS Institute). Donor was modeled as a random effect. Within a donor, the correlation between analyte levels measured for the same treatment at adjacent time points was modeled using a 1^st^ order autoregressive covariance structure. Treatment, disease, and time, as well as their interactions, were modeled as fixed effects. Fold induction of analytes and differences between asthmatic and non-asthmatic donors were assessed by calculating the appropriate model contrasts. The significance level used for all analyses was p\< = 0.05.

RNA-seq preparation and bioinformatics analysis {#sec011}
-----------------------------------------------

RNA sequencing was performed on an Illumina HiSeq2000 platform. Library construction and sequencing were performed by the Beijing Genomics Institute (BGI) analysis pipeline (RefSeq version HG19). RNA-seq data was deposited to GEO (GSE61141). A non-parametric Spearman's correlation test was performed for identification of genes whose expression changes have the strongest correlation with viral titer (FDR q-value ≤ 1%). Statistical significance (nominal p-values) was corrected for multiple hypotheses testing with the Bejamini and Hochberg method \[[@pone.0118286.ref021]\]. A linear regression analysis was used to adjust analyses for confounding variables. To identify genes with baseline differences, a Wilcoxon rank test was performed to test the difference in gene expression between asthmatic and non-asthmatic vehicle samples. The resulting p-values were not adjusted for multiple hypothesis testing because the small sample size provided fairly limited detection power (with only 579 genes showing p-value \< 0.05). Although some of these genes could be false positives due to multiple testing, many of them do appear to be functionally relevant. Gene expression pathway analysis was performed using Gene Ontology and MSigDB with hypergeometric test \[[@pone.0118286.ref022],[@pone.0118286.ref023]\].

Results {#sec012}
=======

RV-A16 infection of HAECs in ALI cultures {#sec013}
-----------------------------------------

We first investigated the infectivity of RV-A16 in ALI cultured HAECs by quantifying RV-A16 viral load (RNA) in cell lysates at 1.5, 8 and 24 hours post exposure (p.e.) using qRT-PCR. Passage 2 HAECs obtained from 6 asthmatics and 6 non-asthmatics ([Table 1](#pone.0118286.t001){ref-type="table"}), cultured as differentiated multilayer ALI cultures, were infected with either RV-A16 at 5x10^5^ pfu in 50 μL medium or vehicle control (medium alone) on the apical surface (see [Methods](#sec006){ref-type="sec"}). Results showed time-dependent viral load increases, which reached maximum at 24 hours p.e. ([Fig. 1A](#pone.0118286.g001){ref-type="fig"}), indicating that ALI culture systems are effectively infected by RV-A16. Cell lysates at 48 hours p.e. were not included in the analysis, as viral load was significantly decreased in cell lysate, due to rhinovirus shedding from cells into culture medium at this time point. We noted that, unlike cells from other donors, ALI cultured HAECs from non-asthma donor 23 and asthma donors 14 and15 had a decreased viral load from 8 hour to 24 hour p.e. ([Fig. 1B](#pone.0118286.g001){ref-type="fig"}). However, no statistically significant differences in viral load were observed between asthmatic and non-asthmatic derived cultures ([Fig. 1A](#pone.0118286.g001){ref-type="fig"}). Anti-dsRNA antibody J2 (mabJ2) \[[@pone.0118286.ref020]\] was utilized to detect replicating HRV genomes by immunofluorescence staining. Positive staining was observed at the apical side of ALI cultured HAECs, confirming that ALI cultures were infectable and enabled HRV replication ([Fig. 2](#pone.0118286.g002){ref-type="fig"}).

![Time course of RV-A16 infection for asthmatic (n = 6) and non-asthmatic (n = 6) donor groups (A) and each donor (B) in ALI cultures.\
Viral genome levels in cell lysates were measured by qPCR at three time points, and were presented as viral RNA copies /culture. There was no significant difference in the mean viral genome levels between asthmatic and non-asthmatic samples. The p values between asthma and non-asthmatic samples are 0.48, 0.53 and 0.13 at 1.5, 8, and 24 hours post exposure (p.e.) respectively.](pone.0118286.g001){#pone.0118286.g001}

![ALI cultured HAECs were infectible by RV-A16.\
Immunofluorescence micrographs of transverse sections of ALI cultures shows RV-A16 replicated in ALI cultured HAECs. Positive immunofluorescence staining for mabj2 (in green) was not observed in uninfected control tissues (top panel), but was observed in RV-A16 infected tissues (bottom panel); DAPI staining in blue shows cell nuclei in the tissues. Scale bars: 50 μm.](pone.0118286.g002){#pone.0118286.g002}

Genome-wide gene expression profiles of ALI HAEC cultures following RV-A16 infection {#sec014}
------------------------------------------------------------------------------------

We next utilized genome-wide RNA-seq analysis to investigate whether non-asthmatic and asthmatic ALI HAEC cultures exhibited differential gene expression at baseline, and/or after HRV infection. ALI cultures infected by RV-A16 at 24 hours p.e were chosen for the analysis because our analysis of expression changes of selected genes at different time points after viral infection indicated that the most robust responses were induced by RV-A16 at 24 hours p.e., which also correlated with the highest viral content in cells (not shown).

To identify genes whose expression was affected by viral infection, we performed a non-parametric Spearman's correlation test on RNA-seq gene expression data from the samples treated with vehicle or RV-A16 across all 12 donors. We identified 1,485 genes that had strongest correlation with viral infection (FDR q-value ≤ 1%), among which 457 were up-regulated (see [S1 Dataset](#pone.0118286.s003){ref-type="supplementary-material"}). Gene expression pathway analysis of these genes identified 10 functional pathways that showed statistically significant differential expression between RV-A16 and vehicle groups ([Fig. 3](#pone.0118286.g003){ref-type="fig"}). Genes from 4 pathways, including those involved in mRNA synthesis, adherens junction, epithelial cilium movement and cilium morphogenesis, had significantly down-regulated expression in RV-A16 infected cells compared to vehicle treated cells ([Fig. 3](#pone.0118286.g003){ref-type="fig"}). This finding is consistent with host cell transcription shut off, disruption of HAEC polarity, and ciliated cell dysplasia due to RV-A16 infection. An additional 6 pathways that were significantly increased after viral infection were involved in type I and type II interferon responses, apoptosis, innate immune responses, a Th2 signature from Woodruff \[[@pone.0118286.ref024],[@pone.0118286.ref025]\] and pathways for regulation of viral production ([Fig. 3](#pone.0118286.g003){ref-type="fig"} and [S2 Dataset](#pone.0118286.s004){ref-type="supplementary-material"}).

![Functional pathways that showed statistically significant differential expression between RV-A16 and Vehicle groups (p\<0.05).\
Outliner is shown individually with a solid circle.](pone.0118286.g003){#pone.0118286.g003}

We further compared the genome-wide RNA-seq expression changes observed in our RV-A16-infected ALI cultures to *in vivo* gene signature data obtained from nasal scrapings at 48 hours after RV-A16 challenge as previously reported by Proud and coworkers \[[@pone.0118286.ref026]\]. There are 452 up-regulated genes in our study that map to Refseq genes, and 381 upregulated genes in the Proud study. The overlap is 61 genes (p = 2.2e-28) ([S3 Dataset](#pone.0118286.s005){ref-type="supplementary-material"}). GeneGO pathways analysis revealed that pathways enriched in these genes are immune response (p = 2.575E-20), defense response to virus (p = 7.387E-20) and interferon signaling (p = 2.955E-18). In addition, there are 1041 down-regulated genes in our dataset (mapped to Refseq), and 256 in the Proud study. The overlap is 35 (p = 2.3E-5) ([S3 Dataset](#pone.0118286.s005){ref-type="supplementary-material"}), which enriched Th2 signature in lung epithelial brushings from Woodruff studies (p = 0.026) \[[@pone.0118286.ref024],[@pone.0118286.ref025]\].

Asthma-specific baseline gene expression profiles in ALI cultured HAECs {#sec015}
-----------------------------------------------------------------------

To investigate whether asthmatic HAECs still maintained a distinct gene expression profile from non-asthmatic cells in ALI cultures, a non-parametric Wilcoxon-test was used to compare the rank-order of gene expression between vehicle treated samples from two donor groups (asthma vs. non-asthma). Although the magnitude of gene expression differences between asthma and non-asthma groups was overall quite low, a total of 579 genes were identified as differentially expressed with statistical significance (p\<0.05). This list includes 346 with increased expression, and 233 with reduced expression in vehicle treated asthmatic compared to non-asthmatic cultures ([S4 Dataset](#pone.0118286.s006){ref-type="supplementary-material"}). Function pathway analysis revealed a strong Th-2 signature and cilium function signature in asthmatic samples. Twenty-three genes with reduced expression in asthmatic samples coincided with the down-regulated arm of a Th-2 signature generated in lung epithelial brushings as reported previously by Woodruff *et al* \[[@pone.0118286.ref024],[@pone.0118286.ref025]\] ([S5 Dataset](#pone.0118286.s007){ref-type="supplementary-material"}). This finding suggests that asthmatic donors in this study primarily may be Th-2 type. Additionally, 12 down-regulated genes were related to cilium function, demonstrating that gene signature of ciliary dysfunction, a feature of moderate to severe asthma pathophysiology \[[@pone.0118286.ref027]\], was preserved in ALI cultures even after 2 passages *in vitro*.

Asthmatic-specific viral response gene expression profiles in ALI cultured cells {#sec016}
--------------------------------------------------------------------------------

We next sought to identify genes that responded to HRV differently between asthmatic and non-asthmatic groups. By fitting a linear mixed-effects model, we identified a total of 497 genes with nominally significant difference (p\< 0.05) in viral infection response between asthmatic and non-asthmatic groups ([S6 Dataset](#pone.0118286.s008){ref-type="supplementary-material"}). Of these, 46 genes had expression changes strongly associated with RV-A16 infection ([Fig. 4](#pone.0118286.g004){ref-type="fig"}). Notably, 8/46 genes also showed differential expression at baseline in the vehicle treated cells, indicating these genes were intrinsically different in expression between asthmatic and non-asthmatic donors prior to viral infection ([Table 2](#pone.0118286.t002){ref-type="table"}). For example, chemokine (C-C motif) ligand 5 (CCL5), also known as RANTES, previously reported to be genetically associated with asthma \[[@pone.0118286.ref028],[@pone.0118286.ref029]\], is differentially expressed between asthmatic and non-asthmatic cultures at both baseline (p = 0.026) and post viral infection (p = 0.047). Its expression increased 1.86 fold after viral infection and the increase highly correlated with viral load (correlation co-efficient = 0.982). 38/46 genes showed strong differential expression associated with asthma-related viral infection, but without baseline difference in expression prior to viral infection ([Table 3](#pone.0118286.t003){ref-type="table"}). Notably, the expression of CXCL10 (IP10), a chemoattractant for type I lymphocyte and NK cells, and previously proposed as a biomarker of human HRV infection and exacerbation of COPD \[[@pone.0118286.ref030]\], significantly increased 3.4 fold higher in asthmatic cells after viral infection, compared to non-asthmatic cells (p = 0.005). Our analysis identified 52 genes that showed differential expression between asthma and non-asthma donor cells at the baseline, but not after viral infection, although they were strongly responsive to viral infection ([Table 4](#pone.0118286.t004){ref-type="table"}). Interestingly, the changes in expression of lectin galactoside-binding soluble 9 (LGALS9) \[[@pone.0118286.ref031]\], chemokine (C-X3-C motif) ligand 1 (CX3CL1) \[[@pone.0118286.ref032]\] and complement component 5a receptor 1 (C5AR1) \[[@pone.0118286.ref033]\] have been previously reported to be associated with asthma. Cadherin related family member 3 (CDHR3) was recently reported to be genetically associated with early childhood severe and recurrent asthma exacerbation, and highly expressed in airway epithelium \[[@pone.0118286.ref034]\]. CDHR3 encodes a hemophilic cell adhesion molecule, which may be involved in maintaining cell integrity by forming cell-cell junctions. In this study, we found its expression was significantly lower in asthmatic epithelial cells compared to non-asthmatic cells at the baseline (p = 0.02) ([S4 Dataset](#pone.0118286.s006){ref-type="supplementary-material"}), consistent with the previous report that showed its expression was down-regulated in allergic asthma subjects \[[@pone.0118286.ref024]\] ([S5 Dataset](#pone.0118286.s007){ref-type="supplementary-material"}). Importantly its expression was further decreased upon viral infection (HRV vs. Veh p\<0.0001) and its reduction was highly correlated with viral infection (Pearson correlation p value = 1.6e-04 and q value = 2.944e-03) ([S1 Dataset](#pone.0118286.s003){ref-type="supplementary-material"}). Our data provide evidence for further disrupted function of CDHR3 in HRV-induced asthma exacerbation.

![Distributions of differentially expressed genes in asthmatic samples after treatment of vehicle or RV-A16.\
579 genes in the "Asthma vs. non-asthma at baseline" group had baseline difference between asthmatic and non-asthmatic cells (p\<0.05); 497 genes in the "Asthma vs. non-asthma after HRV infection" group had asthma-related viral response (p\<0.05); and 1485 genes in the "HRV response group had strong expression changes associated with viral infection across both asthma and non-asthma donors. The numbers of genes only in one group or common for either two or three groups are shown by either exclusive or overlapping areas in Venn diagrams. The diagrams were generated with an online tool available at <http://bioinfogp.cnb.csic.es/tools/venny/>.](pone.0118286.g004){#pone.0118286.g004}

10.1371/journal.pone.0118286.t002

###### Differentially expressed genes between asthma and non-asthma groups both at baseline and after HRV 16 infection.

![](pone.0118286.t002){#pone.0118286.t002g}

  Gene Symbol   Gene name                                                          Biological function          Base line difference p-value   Differential viral response (As vs. non-As)   Viral infection correlation p-value   
  ------------- ------------------------------------------------------------------ ---------------------------- ------------------------------ --------------------------------------------- ------------------------------------- ---------
  CCRL1         chemokine (C-C motif) receptor-like 1                              decoy chemokine receptor     0.002                          1.686                                         0.049                                 4.1E-06
  LRIG1         Leucine-rich repeats and immunoglobulin-like domains protein 1     protein binding              0.004                          0.528                                         0.016                                 2.8E-07
  ERBB4         v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)   a receptor tyrosine kinase   0.009                          1.358                                         0.037                                 2.6E-07
  RNF44         ring finger protein 44                                             protein binding              0.009                          0.701                                         0.044                                 2.7E-06
  STARD4        StAR-related lipid transfer (START) domain containing              lipid transport              0.015                          1.857                                         0.013                                 6.6E-10
  CCL5          chemokine (C-C motif) ligand 5                                     chemokine                    0.026                          1.857                                         0.047                                 2.6E-14
  LOC388692     hypothetical LOC388692                                             NA                           0.026                          1.432                                         0.043                                 7.4E-07
  KLHDC3        kelch domain containing 3                                          protein binding              0.041                          0.581                                         0.028                                 2.1E-06

10.1371/journal.pone.0118286.t003

###### Differentially expressed genes between asthma and non-asthma groups after HRV 16 infection.

![](pone.0118286.t003){#pone.0118286.t003g}

  Gene Symbol   Gene name                                                             Biological function                                  Differential viral response (As vs. non-As)   Viral infection correlation p-value   
  ------------- --------------------------------------------------------------------- ---------------------------------------------------- --------------------------------------------- ------------------------------------- ---------
  CXCL10        chemokine (C-X-C motif) ligand 10                                     chemokine                                            3.353                                         0.005                                 9.5E-15
  ZBP1          Z-DNA binding protein 1                                               DNA binding                                          1.522                                         0.050                                 2.9E-15
  C19orf66      chromosome 19 open reading frame 66                                   NA                                                   1.402                                         0.046                                 1.2E-14
  GBP5          guanylate binding protein 5                                           Guanylate binding protein                            1.634                                         0.035                                 9.5E-13
  NUB1          negative regulator of ubiquitin-like proteins 1                       protein binding                                      1.548                                         0.030                                 1.3E-12
  C1orf38       chromosome 1 open reading frame 38                                    NA                                                   1.891                                         0.012                                 7.1E-12
  TICAM1        toll-like receptor adaptor molecule 1                                 protein binding, anti-viral defense, apoptosis       1.477                                         0.043                                 6.5E-12
  APOBEC3F      apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F   protein binding, RNA binding, anti-viral defense     1.558                                         0.035                                 4.1E-10
  BCL7A         B-cell CLL/lymphoma 7A                                                negative regulation of transcription                 0.513                                         0.017                                 6.9E-08
  FAM104B       family with sequence similarity 104, member B                         NA                                                   0.592                                         0.049                                 3.0E-08
  CCDC109B      coiled-coil domain containing 109B                                    ion channel activity                                 1.844                                         0.043                                 2.1E-07
  PARP8         ubiquitin specific peptidase 15                                       NA                                                   1.556                                         0.021                                 7.0E-08
  GCLC          glutamate-cysteine ligase, catalytic subunit                          glutamate cystein ligase activity                    0.654                                         0.022                                 1.4E-06
  FAM60A        family with sequence similarity 60, member A                          protein binding                                      0.624                                         0.007                                 8.4E-08
  KCNQ4         potassium voltage-gated channel, KQT-like subfamily, member 4         ion channel activity                                 2.106                                         0.026                                 2.1E-06
  VGLL4         vestigial like 4 (Drosophila)                                         transcription                                        0.701                                         0.032                                 1.3E-07
  GOLPH3L       golgi phosphoprotein 3-like                                           protein binding                                      0.681                                         0.037                                 2.2E-06
  LIMS1         LIM and senescent cell antigen-like domains 1                         protein binding                                      0.543                                         0.004                                 1.1E-06
  USP15         ubiquitin specific peptidase 15                                       enzyme activity                                      1.453                                         0.035                                 1.2E-06
  PEX6          peroxisomal biogenesis factor 6                                       protein binding                                      0.555                                         0.045                                 4.9E-06
  FHOD1         formin homology 2 domain containing 1                                 protein binding, actin binding                       0.592                                         0.044                                 6.0E-06
  FXR1          fragile X mental retardation, autosomal homolog 1                     RNA binding                                          0.709                                         0.020                                 1.2E-06
  IARS2         isoleucyl-tRNA synthetase 2, mitochondrial                            ATP binding, aminoacyl -tRNA editing activity        0.708                                         0.016                                 2.7E-06
  PTPLAD2       protein tyrosine phosphatase-like A domain containing 2               lysase activity                                      0.426                                         0.010                                 6.1E-05
  SLC23A2       solute carrier family 23 (nucleobase transporters), member 2          nucleobase transporter                               0.670                                         0.048                                 1.0E-05
  PELI1         pellino homolog 1 (Drosophila)                                        protein binding, ubiquitin-protein ligase activity   1.754                                         0.020                                 1.1E-05
  TMCC2         transmembrane and coiled-coil domain family 2                         protein binding                                      0.490                                         0.013                                 6.9E-06
  LRRC3         leucine rich repeat containing 3                                      protein binding                                      1.671                                         0.030                                 2.7E-05
  DHX32         DEAH (Asp-Glu-Ala-His) box polypeptide 32                             helicase activity, ATP binding                       0.601                                         0.049                                 5.7E-05
  IVD           isovaleryl-CoA dehydrogenase                                          metabolic pathway                                    0.643                                         0.043                                 2.4E-05
  ZFHX2         zinc finger homeobox 2                                                transcription                                        0.606                                         0.022                                 4.4E-05
  PDK2          pyruvate dehydrogenase kinase, isozyme 2                              metabolic pathway                                    0.482                                         0.023                                 4.4E-05
  RBBP4         retinoblastoma binding protein 4                                      protein binding, histone binding                     0.758                                         0.044                                 2.3E-06
  VAT1          vesicle amine transport protein 1 homolog (T. californica)            transporter                                          0.568                                         0.029                                 2.9E-05
  CACNA1D       calcium channel, voltage-dependent, L type, alpha 1D subunit          ion channel activity                                 0.705                                         0.046                                 3.9E-05
  TTLL1         tubulin tyrosine ligase-like family, member 1                         cilium function                                      0.492                                         0.012                                 8.2E-05
  ANKMY1        ankyrin repeat and MYND domain containing 1                           protein binding, metal ion binding                   0.491                                         0.047                                 3.7E-04

10.1371/journal.pone.0118286.t004

###### Differentially expressed genes between asthma and non-asthma groups at baseline and also significantly responsive to RV-A16 infection.
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  Gene Symbol   Gene name                                                                                   Biological function                               Baseline difference P-value   Viral infection correlation p-value
  ------------- ------------------------------------------------------------------------------------------- ------------------------------------------------- ----------------------------- -------------------------------------
  BBS1          Bardet-Biedl syndrome 1                                                                     Acetylation, cilia assembly                       0.0022                        2.7E-08
  LGALS9        lectin, galactoside-binding, soluble, 9                                                     Cell adhesion                                     0.0043                        7.1E-11
  BAZ1A         bromodomain adjacent to zinc finger domain, 1A                                              Transciption                                      0.0087                        4.6E-08
  CX3CL1        chemokine (C-X3-C motif) ligand 1                                                           Chemokine                                         0.0087                        3.5E-09
  KIAA0232      KIAA0232                                                                                    Unknown                                           0.0087                        5.5E-08
  SAP30         Sin3A-associated protein, 30kDa                                                             Transciption                                      0.0087                        5.6E-08
  APOBEC4       apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative)               mRNA editing                                      0.0152                        3.1E-06
  BTN3A3        butyrophilin, subfamily 3, member A3                                                        T cell mediated immunity                          0.0152                        1.5E-07
  CCDC30        coiled-coil domain containing 30                                                            Unknown                                           0.0152                        7.4E-05
  FAM81A        family with sequence similarity 81, member A                                                Unknown                                           0.0152                        2.7E-06
  IFI30         interferon, gamma-inducible protein 30                                                      Superoxide anion generation                       0.0152                        1.7E-09
  KIAA0319      KIAA0319                                                                                    Cell adhesion                                     0.0152                        1.2E-05
  KLC4          kinesin light chain 4                                                                       Microtubule motor activity                        0.0152                        1.0E-06
  MARCKSL1      MARCKS-like 1                                                                               Actin binding                                     0.0152                        4.6E-08
  NEK1          NIMA (never in mitosis gene a)-related kinase 1                                             Cilium assembly                                   0.0152                        3.9E-06
  PRSS12        protease, serine, 12 (neurotrypsin, motopsin)                                               Zymogen activation, exocytosis                    0.0152                        2.2E-07
  RAPGEF5       Rap guanine nucleotide exchange factor (GEF) 5                                              Small GTPase mediated signal transduction         0.0152                        1.8E-08
  WDR52         WD repeat domain 52                                                                         Unknown                                           0.0152                        1.8E-05
  WRB           tryptophan rich basic protein                                                               Unknown                                           0.0152                        3.1E-08
  C1orf88       chromosome 1 open reading frame 88                                                          Cell projection organization                      0.0260                        2.2E-08
  CDHR3         cadherin-related family member 3                                                            Homophilic cell adhesion                          0.0260                        1.6E-04
  CHKA          choline kinase alpha                                                                        Lipid metabolic process                           0.0260                        2.4E-06
  CLOCK         clock homolog (mouse)                                                                       Transciption                                      0.0260                        5.9E-07
  DAB2IP        DAB2 interacting protein                                                                    Negative regulation of cell migration             0.0260                        6.2E-08
  DNAH12        dynein, axonemal, heavy chain 12                                                            Microtubule motor activity                        0.0260                        2.4E-05
  ENDOD1        endonuclease domain containing 1                                                            Unknown                                           0.0260                        1.3E-11
  EPB41L4B      erythrocyte membrane protein band 4.1 like 4B                                               Actomyosin structure organization                 0.0260                        3.8E-06
  GNL3L         guanine nucleotide binding protein-like 3 (nucleolar)-like                                  GTP catabolic process; ribosome biogenesis        0.0260                        2.0E-06
  HIST2H2BE     histone cluster 2, H2be                                                                     Nucleosome assembly                               0.0260                        2.5E-05
  KIAA1377      KIAA1377                                                                                    Unknown                                           0.0260                        9.7E-06
  LRRC6         leucine rich repeat containing 6                                                            cilium movement                                   0.0260                        3.2E-04
  NRG2          neuregulin 2                                                                                Signal transduction                               0.0260                        5.5E-05
  PCM1          pericentriolar material 1                                                                   Cilium assembly                                   0.0260                        5.4E-07
  SPATA6        spermatogenesis associated 6                                                                Cell differentiation                              0.0260                        9.9E-07
  SPICE1        spindle and centriole associated protein 1                                                  Cell division                                     0.0260                        6.9E-08
  TCP11L2       t-complex 11 (mouse)-like 2                                                                 Cell morphogenesis                                0.0260                        1.3E-06
  TMEM67        transmembrane protein 67                                                                    Cilium assembly                                   0.0260                        6.1E-07
  C5AR1         complement component 5a receptor 1                                                          Epithelial cell proliferation                     0.0260                        6.4E-08
  CERKL         ceramide kinase-like                                                                        Negative regulation of cell Apoptosis             0.0411                        3.9E-06
  CNNM3         cyclin M3                                                                                   Ion transport                                     0.0411                        5.2E-07
  DNAH6         dynein, axonemal, heavy chain 6                                                             Microtubule-based movement                        0.0411                        4.0E-05
  DNAL1         dynein, axonemal, light chain 1                                                             Cilium function                                   0.0411                        4.9E-07
  ENKUR         enkurin, TRPC channel interacting protein                                                   Cilium function                                   0.0411                        8.0E-06
  GPR85         G protein-coupled receptor 85                                                               Signal transduction                               0.0411                        1.8E-09
  IFITM1        interferon induced transmembrane protein 1 (9--27)                                          Negative regulation of viral genome replication   0.0411                        1.9E-10
  KIF2A         kinesin heavy chain member 2A                                                               Microtubule-based movement                        0.0411                        5.8E-09
  LOC157381     hypothetical LOC157381                                                                      Unknown                                           0.0411                        2.2E-06
  LOC646851     similar to OTTHUMP00000028720                                                               T cell proliferation                              0.0411                        2.0E-05
  RABGAP1L      RAB GTPase activating protein 1-like                                                        Regulation of protein organization                0.0411                        2.0E-05
  RABL5         RAB, member RAS oncogene family-like 5                                                      Small GTPase mediated signal transduction         0.0411                        4.0E-07
  SYBU          syntabulin (syntaxin-interacting)                                                           Unknown                                           0.0411                        2.4E-08
  PSMB9         proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2)   Cell cycle                                        0.0450                        5.7E-07

Cytokine/chemokine expression changes induced by RV-A16 infection {#sec017}
-----------------------------------------------------------------

To compare protein expression of common cytokines and chemokines induced by HRV between asthmatic and non-asthmatic cells, we measured their expression level in culture medium using a Luminex 42-plex assay. The expression level of 3 analytes (EGF, FGF2, and IL4) was below detection, and 7 analytes (GMCSF, GRO, IL15, IL1beta, IL3, PDGRA and VEGF) were not significantly induced by RV-A16. Thus, these proteins were not included in further analysis. Thirty-two cytokines/chemokines showed significant expression changes upon viral infection ([S7 Dataset](#pone.0118286.s009){ref-type="supplementary-material"}), among which 16 analytes had robust expression levels ([Fig. 5](#pone.0118286.g005){ref-type="fig"}). However, none of them showed any difference between asthmatic and non-asthmatic cells ([S7 Dataset](#pone.0118286.s009){ref-type="supplementary-material"}). Generally, there is a good agreement between proteins and their corresponding genes in terms of their expression change directions (i.e. proteins up-regulated by HRV tend to be up-regulated at the mRNA level).

![Expression of secreted cytokines/chemokines in culture medium.\
16/42 cytokines tested had robust expression levels and were significantly up-regulated at 24 hr after RV-A16 infection across 12 donors (p value\<0.05). Differences were not significant between asthma and non-asthma groups (p\>0.05). Red lines represent asthma samples, blue lines represent non-asthma samples. Each line represents the mean and standard deviation of log2 concentration of each cytokine/chemokine.](pone.0118286.g005){#pone.0118286.g005}

HRV infection induced MUC5AC expression in ALI cultures {#sec018}
-------------------------------------------------------

As mucus hypersecretion relates to HRV-induced asthma exacerbations, MUC5AC protein expression was examined in ALI cultures after RV-A16 infection compared to vehicle treatment by immunofluorescence ([Fig. 6](#pone.0118286.g006){ref-type="fig"}). We observed that basal levels of its expression in vehicle treated tissues were generally higher in non-asthma smokers and asthma donors compared to non-asthma, non-smoker donors, and that its expression level was increased after viral infection ([Fig. 6A and B](#pone.0118286.g006){ref-type="fig"}). However there was no statistical significance in terms of these differences or asthma-related expression changes ([Fig. 6B](#pone.0118286.g006){ref-type="fig"}). Smoking has previously been linked to increased mucus production and MUC5AC gene expression \[[@pone.0118286.ref035]\]. We found that non-asthma smoker donor 23 had three fold higher basal expression level of MUC5AC, whereas non-asthma smoker donor 11 had an expression level of MUC5AC similar to other non-asthma non-smoker donors ([Fig. 6A](#pone.0118286.g006){ref-type="fig"}). Removal of non-asthma smokers (donors 11 and 23) from the data set resulted in significant responses of MUC5AC expression after RV-A16 infection in both non-asthma donors (p = 0.01) and asthma donors (p = 0.0001). Importantly, MUC5AC protein expression level showed asthma-related differences both at vehicle treated baseline (p = 0.05) and after viral infection (p = 0.01) ([Fig. 6C](#pone.0118286.g006){ref-type="fig"}). The MUC5AC gene initially was not included in the gene annotation used to quantitate transcription in RNA-seq analysis. There are, however, reads mapped to the MUC5AC locus. Its FPKM was recalculated using a different genome annotation to quantitate its expression levels. Interestingly, consistent with MUC5AC protein expression results, base line MUC5AC mRNA expression was highest in the non-asthma smoker donor 23 ([S1 Fig.](#pone.0118286.s001){ref-type="supplementary-material"}). When both non-asthma smoker donors 23 and 11 were removed from analysis, MUC5AC gene expression level showed both significant response to RV-A16 infection (p = 0.016 and p = 0.004 for non-asthma and asthma groups respectively), and asthma-related differential viral response between the asthma and non-asthma groups (p = 0.047) ([S2 Fig.](#pone.0118286.s002){ref-type="supplementary-material"}).

![MUC5AC expression is upregulated in response to HRV infection.\
A) Immunofluorescence of MUC5AC in ALI cultures from donors 21 (non-asthma, non-smoker), 23 (non-asthma, smoker), 26 (asthma, non-smoker) and 11(asthma, smoker) show an increase in staining with HRV treatment, with only donor 23 having high baseline expression. Green: MUC5AC, blue: DAPI staining for nuclei, representative images, scale bar: 50 μm. N = 6 ALI cultures per group (asthma and non-asthma). B and C) Quantification of immunofluorescence staining presented as either dot plot (B) or box plot (C). Positively stained area was measured and presented as % of total epithelial area. Red dots indicate outliers (\> 1.5x inter-quartile distance). B) Inclusion of all data from 6 non-asthmatic and 6 asthmatic donors in analysis. C) Removal of non-diseased smokers (donors 11 and 23) from the data set results in significant differences between HRV and vehicle treated tissues in both non-asthmatic and asthmatic donors as determined by ANOVA and Tukey HSD test.](pone.0118286.g006){#pone.0118286.g006}

Discussion {#sec019}
==========

Some previous studies reported that differentiated HAECs were more resistant to HRV infection compared to undifferentiated cells, because only fewer than 5% of the differentiated cells were infected \[[@pone.0118286.ref010]\]\[[@pone.0118286.ref018]\]. However, using our current infection protocol, we found that differentiated ALI cultured HAECs can be effectively infected by RV-A16, based on quantitative analysis of viral RNA in cell lysates ([Fig. 1](#pone.0118286.g001){ref-type="fig"}) and IHC analysis for viral replication dsRNA intermediates that showed most apically located cells were infected ([Fig. 2](#pone.0118286.g002){ref-type="fig"}). This discrepancy might result from the different duration of viral exposure on HAECs. In this study, we tried to mimic the *in vivo* situation where once HRV gets into the respiratory tract, the epithelium is exposed to viral infection for an extended period of time until possible complete or partial clearance. Mucus was also rinsed from the surface of ALI prior to HRV application in the current study to allow better attachment of HRV to epithelial cells. Thus, RV-A16 was left in the culture until cells were harvested for analysis, whereas previously reported studies only allowed 1 to 6 hr viral exposure, then virus was removed from culture \[[@pone.0118286.ref010],[@pone.0118286.ref018]\]. We speculate that ALI cultured HAE cells may require a longer time for effective HRV infection. This may be due to low numbers of ICAM-1 receptors on the membranes of apical surface cells in ALI cultures \[[@pone.0118286.ref036]\]. Some other studies have also successfully shown HRV infection in ALI cultured airway epithelial cells \[[@pone.0118286.ref037],[@pone.0118286.ref038],[@pone.0118286.ref039],[@pone.0118286.ref040]\], and demonstrated optimal replication of some strains from RV-A and RV-C classes can be achieved only when the virus is added apically \[[@pone.0118286.ref040]\], emphasizing the importance of polarized ALI cultures for viral infection study.

We observed robust responses in ALI cultured HAECs elicited by RV-A16 infection. The RNA-seq analysis identified 1485 genes that are significantly responsive to viral infection in HAEC ALI cultures at 24 hours post exposure. This set of genes included all the anti-viral pathway components identified by Chen et al. in non-asthmatic ALI cultured airway epithelial cells \[[@pone.0118286.ref018]\]. Importantly, these 1485 genes also showed a significant overlap with those from the *in vivo* dataset previously reported by Proud and coworkers \[[@pone.0118286.ref026]\] ([S3 Dataset](#pone.0118286.s005){ref-type="supplementary-material"}), demonstrating that some important patterns of gene expression changes observed in nasal scrapes during clinical RV-A16 infection in subjects can be reproduced in the ALI cultured second passage HAECs, in spite of differences between cell types in these two studies. Taken together, we conclude that the ALI cultured HAECs infected with HRV represent a translational *in vitro* model for capturing *in vivo* rhinoviral infection responses. Our ALI culture model is composed of epithelial cells, but lacks immune system cells such as dendritic cells, macrophages, T cells, eosinophils, which are known to be important players in viral sensing, amplification of antiviral response and allergic inflammation in airways \[[@pone.0118286.ref003]\]. Studies using blood cells \[[@pone.0118286.ref041]\] or a coculture system including both HAECs and other cell types such as dendritic cells, and/or lymphocytes should allow us to gather a more complete picture of HRV infection responses that occur *in vivo*.

The major limitation of this study is a relatively small number of samples (6 asthmatic, 6 non-asthmatic cells), which have heterogeneous characteristics such as smoking history, and other diseases ([Table 1](#pone.0118286.t001){ref-type="table"}). Nevertheless, we observed significant, strong asthma specific Th-2 and cilium function signatures in control ALI cultures ([S4 Dataset](#pone.0118286.s006){ref-type="supplementary-material"}). These signatures are consistent with features of moderate to severe asthma pathophysiology previously described *in vivo* \[[@pone.0118286.ref024],[@pone.0118286.ref025],[@pone.0118286.ref027]\]. Collectively, these results demonstrate that common asthmatic features may still be identified by gene expression signatures despite small sample size and a heterogeneous background of donor samples. In addition, we noted that cells derived from non-asthmatic donor 23 behaved differently from other non-asthmatic samples in some respects. For example, donor 23 cells were less infected by RV-A16 at 24 hrs ([Fig. 1](#pone.0118286.g001){ref-type="fig"}), despite having similar levels of ICAM1 gene expression compared to other non-asthmatic donor cells before and after RV-A16 infection ([S1 Dataset](#pone.0118286.s003){ref-type="supplementary-material"}). It is unclear if donor 23 cells behaved differently from other non-asthmatics simply due to smoking history (20PY), since cells from donor 11, also a smoker (16PY), did not display the same resistance to viral infection. Smoking has previously been linked to increased mucus production and MUC5AC gene expression \[[@pone.0118286.ref035]\]. Consistent with this, the ALI culture derived from donor 23 had a higher amount of MUC5AC expression before viral infection ([Fig. 6](#pone.0118286.g006){ref-type="fig"}), but donor 11 had a similar expression level to other non-asthma donors. Recently, the study from Jakiela et al. demonstrated that IL13-induced mucous metaplasia rendered ALI cultured airway epithelial cells less susceptible to HRV infection \[[@pone.0118286.ref038]\]. It is likely that relatively highly increased mucus production may render donor 23 cells less infectable by HRV. Further study on the genetic background of this donor is warranted to understand this phenotype. Nevertheless, due to the relatively small sample size of this study, we included donor 23 in the non-asthmatic group for all analyses.

Conflicting reports exist in the literature regarding defective HRV-induced type I and type III interferon production or increased viral infection in primary HAECs derived from asthma subjects \[[@pone.0118286.ref012],[@pone.0118286.ref042],[@pone.0118286.ref043]\]. The reasons for this are unclear, but is likely influenced by differences \[[@pone.0118286.ref008]\] in experimental techniques (ALI versus submerged cultures) and clinical characteristics of asthmatic subjects from whom the primary HAECs were derived (severe asthmatic subjects in our study versus mild atopic asthmatic donors in others) \[[@pone.0118286.ref008],[@pone.0118286.ref044]\]. We did not observe any significantly differential expression of type III interferon genes (IL28A, IL28B and IL29), or type I interferon gene IFNB1 related to asthma, although they showed robust responses to RV-A16. In addition, we did not observe viral load differences between asthmatic and non-asthmatic cells, which was in good agreement with the recent clinical studies from Kennedy et al., which showed that individuals with and without asthma had similar viral loads after RV-A16 infection \[[@pone.0118286.ref045]\]. Similarly, protein expression of IL6 and IL8 was significantly induced upon viral infection, but no significant differential expression was observed between asthma and non-asthma groups.

Among the 1485 genes associated with HRV infection, three groups were categorized based on differential expression changes either at baseline or after RV-A16 infection between asthmatic and non-asthmatic cells. The first group included 8 genes with differential expression both at baseline and after RV-A16 infection. The second group included 38 genes with differential expression only after viral infection, and the third group had 52 genes with differential expression only at baseline ([Fig. 4](#pone.0118286.g004){ref-type="fig"}). Interestingly, genes previously associated with asthma, such as CCL5 (RANTES), CXCL10 (IP10), LGALS9, CX3CL1, C5AR1, and CDHR3 fall into these three different groups. Other genes in these three groups included several involved in chemokine signaling such as CCRL1. Notably, many are involved in epithelial cell remodeling and cilia assembly and function, most of which belonged to the third group and also were found as part of Th2 signature in lung epithelial brushings from Woodruff studies, and cilium signature from Swiss Protein keywords (LRIG1, KLHDC3, ERBB4, FHOD1, TTLL1, BBS1, KIAA0319, NEK1, C1orf88, DAB2IP, DNAH12, EPB41L4B, LRRC6, PCM1, TCP11L2, TMEM67, DNAH6, DNAL1, ENKUR, KIF2A). These findings provide evidence that ALI cultured HAECs derived from asthmatic donors have fundamental structural differences at baseline in the absence of infection, and these differences can be further exacerbated by RV-A16 infection at least by gene expression standards. It is important to note that, although differences in gene signatures of immune and defense responses between asthma and non-asthma cells were commonly identified in both ALI and submerged cultures, these structural gene expression differences were not revealed when undifferentiated submerged cultures were used for study \[[@pone.0118286.ref008]\].

Taken together, we have demonstrated that ALI cultured HAECs can be effectively infected with RV-A16, and produce robust responses. Given that 1) ALI has morphological and structural features associated with differentiated cells; 2) ALI culture can be infected with HRV using the protocol reported in the current study; and 3) as demonstrated here, the *in vitro* viral response gene expression changes aligns with patient data as recently reported \[[@pone.0118286.ref024],[@pone.0118286.ref026],[@pone.0118286.ref044]\], we propose that ALI cultured HAECs be a sensitive translational model to study HRV-induced changes in HAECs. Furthermore, using RNA-seq, we identified unique asthma-specific expression patterns both at baseline and after RV-A16 infection in ALI cultured HAECs. Besides inflammatory signaling, these differential expression patterns were largely structurally related, and involved in epithelial cell remodeling, cell-cell junctions and cilium assembly and function. These findings provide additional evidence that abnormal airway structure, physiology and inflammatory conditions are important contributors to asthma, which may be further exacerbated by HRV infection.
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======================

###### A dot plot of MUC5AC RNA-seq expression in 12 donors after treatment of vehicle (Veh) or RV-A16 (HRV) for 24 hours.

MUC5AC mRNA expression level based on RNA-seq reads was quantitated using a different annotation genome. Non-asthma donor 23 had the highest expression of MUC5AC at baseline and after HRV infection.

(PDF)

###### 

Click here for additional data file.

###### A box plot of MUC5AC RNA-seq expression in 10 donors after treatment of vehicle (Veh) or RV-A16 (HRV) for 24 hours.

Removal of non-diseased smokers (donors 11 and 23) from the data set results in significant differences between HRV and vehicle treated tissues in both non-asthmatic and asthmatic donors, and significant differential responses to HRV between asthma and non-asthma groups as determined by ANOVA and Tukey HSD test.

(PDF)

###### 

Click here for additional data file.

###### A list of 1485 genes whose expression changes are strongly correlated with viral infection.

(XLSX)

###### 

Click here for additional data file.

###### Lists of genes in 10 functional groups that show statistically significant differential changes in gene expression after viral infection.

(XLSX)

###### 

Click here for additional data file.

###### Lists of RV-A16 responsive genes that are overlapped between *in vitro* HAECs from the current study and *in vivo* nasal scrapings reported in the Proud study.

(XLSX)

###### 

Click here for additional data file.

###### A total of 579 genes with significant baseline differential expression in ALI cultured HAECs from asthmatic compared to non-asthmatic donors (p\<0.05).

(XLSX)

###### 

Click here for additional data file.

###### Genes related to Th-2 signature or cilium function that have significant baseline differential expression between asthmatic and non-asthmatic ALI samples.

(XLSX)

###### 

Click here for additional data file.

###### A list of 497 genes that showed marginally significant difference in viral induced gene expression changes between asthmatic between non-asthmatic ALI samples (nominal p \<0.05).

(XLSX)

###### 

Click here for additional data file.

###### A list of cytokines/chemokines in the Luminex 42-plex assay panel whose expression levels had significant changes upon viral infection.

(XLSX)

###### 

Click here for additional data file.
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